Autologous Endothelial Progenitor Cells Transplantation for Chronic Ischemic Stroke


Phase 1/2 Results N/A

Summary of Purpose

Stroke is a frequently occurring and common diseases in nervous system,and most of the survivors will remain disorders of motor,sensory and cognition function.Stem cell transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy and safy of the transplantation of autologous endothelial progenitor cells in patients with chronic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 November 2015.

1 Nov 2014 12 Nov 2015 1 Nov 2017 1 Nov 2017 1 Nov 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • ZhenZhou Chen, MD, phD